TWELVE YEARS OF EXPERIENCE USING CHOLECYSTOJEJUNAL BY-PASS FOR PALLIATIVE TREATMENT OF ADVANCED PANCREATIC CANCER

ABSTRACT Background: The cholecistojejunal bypass is an important resource to treat obstructive jaundice due to advanced pancreatic cancer. Aim: To assess the early morbidity and mortality of patients with pancreatic cancer who underwent cholecystojejunal derivation, and to assess the success of this procedure in relieving jaundice. Method: This retrospective study examined the medical records of patients who underwent surgery. They were categorized into early death and non-early death groups according to case outcome. Results: 51.8% of the patients were male and 48.2% were female. The mean age was 62.3 years. Early mortality was 14.5%, and 10.9% of them experienced surgical complications. The cholecystojejunostomy procedure was effective in 97% of cases. There was a tendency of increased survival in women and patients with preoperative serum total bilirubin levels below 15 mg/dl. Conclusion: Cholecystojejunal derivation is a good therapeutic option for relieving jaundice in patients with advanced pancreatic cancer, with acceptable rates of morbidity and mortality.

[1]  G. J. Lopes-Filho,et al.  SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS , 2016, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[2]  O. Torres,et al.  THE LARGEST WESTERN EXPERIENCE WITH HEPATOPANCREATODUODENECTOMY: LESSONS LEARNED WITH 35 CASES , 2016, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[3]  A. Mello,et al.  Predictor factors for choledocholithiasis , 2015, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[4]  M. Hornbrook,et al.  A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction. , 2014, Journal of Pain and Symptom Management.

[5]  Tibor Schuster,et al.  Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages , 2010, PLoS medicine.

[6]  P. Allen,et al.  Surgical Treatment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Evans et al. , 2009, Annals of Surgical Oncology.

[7]  A. Dennison,et al.  Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma. , 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[8]  Jeffrey E. Lee,et al.  Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Macmathuna,et al.  Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction , 2007, European journal of gastroenterology & hepatology.

[10]  P. Macmathuna,et al.  Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. , 2007, Cancer treatment reviews.

[11]  E. Artifon,et al.  Surgery or Endoscopy for Palliation of Biliary Obstruction Due to Metastatic Pancreatic Cancer , 2006, The American Journal of Gastroenterology.

[12]  N. Malats,et al.  Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage , 2005, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[13]  T. Ohtsuka,et al.  Surgical bypass versus metallic stent for unresectable pancreatic cancer. , 2001, Journal of hepato-biliary-pancreatic surgery.

[14]  S. Ashley,et al.  Palliation for pancreatic cancer , 1996, Surgical Endoscopy.

[15]  E. Alstead,et al.  Symptom relief and quality of life after stenting for malignant bile duct obstruction. , 1994, Gut.

[16]  J. Richardson,et al.  Effective Palliation of Malignant Biliary Duct Obstruction , 1985, Annals of surgery.

[17]  L. Rikkers,et al.  Biliary obstruction and host defense failure. , 1982, The Journal of surgical research.

[18]  I. Yusuf,et al.  Management of patients with obstructive jaundice: experience in a developing country. , 2011, Nigerian quarterly journal of hospital medicine.

[19]  A. Marrazzo,et al.  Surgical palliation for malignant obstructive jaundice:our experience , 2006 .

[20]  J. Cameron,et al.  Surgical management of unresectable carcinoma of the pancreas. , 1982, Surgery.